Pathway tool
Webcast
Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Introduction to the program Program director Faculty Learning objectives Accreditation Educational grant Introduction to the program Why might this benefit you? With the increasing number of treatment options available for patients with EGFR mutation-positive […]
Targeting improved outcomes in EGFR-mutated NSCLC
Webcast Discussion and guidance on the characterization of EGFR mutation-positive tumor subtypes, appropriate sequencing of treatment and management of EGFR TKI resistance. Pathway Follow a patient’s progression using this interactive pathway as we support your clinical treatment decision-making supported by trial data and expert opinion. An expert-driven program addressing the optimal treatment strategy for patients […]
